The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status.

Authors:
Christopher G Pelic
Christopher G Pelic
Ralph H. Johnson VA Medical Center
James Fox
James Fox
Massachusetts Institute of Technology
United States
Gregory Sahlem
Gregory Sahlem
Medical University of South Carolina
United States
Sophie Robert
Sophie Robert
South Carolina College of Pharmacy
United States
Gonzalo J Revuelta
Gonzalo J Revuelta
Medical University of South Carolina

J Psychiatr Pract 2017 May;23(3):191-199

FRYML, WILLIAMS, PELIC, FOX, SAHLEM, ROBERT, and SHORT: Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, SC REVUELTA: Department of Neurology and Neurosciences, Medical University of South Carolina, Charleston, SC.

Amantadine, which was originally developed as an antiviral medication, functions as a dopamine agonist in the central nervous system and consequently is utilized in the treatment of Parkinson disease, drug-induced extrapyramidal reactions, and neuroleptic malignant syndrome. For reasons that are not entirely understood, abrupt changes in amantadine dosage can produce a severe withdrawal syndrome. Existing medical literature describes case reports of amantadine withdrawal leading to delirium, which at times has progressed to neuroleptic malignant syndrome. Amantadine withdrawal may be under-recognized by mental health clinicians, which has the potential to lead to protracted hospital courses and suboptimal outcomes. The goal of this case series is to highlight the role of amantadine withdrawal in the cases of 3 medically complex patients with altered mental status. In the first case, the cognitive side effects of electroconvulsive therapy masked acute amantadine withdrawal in a 64-year-old man with Parkinson disease. In the second case, a 75-year-old depressed patient developed a catatonic delirium when amantadine was discontinued. Finally, a refractory case of neuroleptic malignant syndrome in a 57-year-old patient with schizoaffective disorder rapidly resolved with the reintroduction of outpatient amantadine. These cases highlight several learning objectives regarding amantadine withdrawal syndrome: First, it may be concealed by co-occurring causes of delirium in medically complex patients. Second, its symptoms are likely to be related to a cortical and limbic dopamine shortage, which may be reversed with electroconvulsive therapy or reintroduction of amantadine. Third, its clinical presentation may occur on a spectrum and may include features suggestive of delirium, catatonia, or neuroleptic malignant syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRA.0000000000000237DOI Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
May 2017
32 Reads

Publication Analysis

Top Keywords

amantadine withdrawal
24
neuroleptic malignant
16
malignant syndrome
16
amantadine
10
role amantadine
8
altered mental
8
complex patients
8
parkinson disease
8
withdrawal syndrome
8
withdrawal cases
8
medically complex
8
electroconvulsive therapy
8
mental status
8
withdrawal
7
syndrome
6
case
5
cases medically
4
courses suboptimal
4
syndrome concealed
4
hospital courses
4

Similar Publications

Optimization of ultrahigh-speed multiplex PCR for forensic analysis.

Anal Bioanal Chem 2018 Jan 29;410(1):235-245. Epub 2017 Nov 29.

Department of Chemistry and Biochemistry and International Forensic Research Institute, Florida International University, University Park, Miami, FL, 33199, USA.

In this paper, we demonstrate the design and optimization of an ultrafast PCR amplification technique, used with a seven-locus multiplex that is compatible with conventional capillary electrophoresis systems as well as newer microfluidic chip devices. The procedure involves the use of a high-speed polymerase and a rapid cycling protocol to permit multiplex PCR amplification of forensic short tandem repeat loci in 6.5 min. Read More

View Article
January 2018
41 Reads
3.44 Impact Factor

A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.

Leuk Lymphoma 2018 04 18;59(4):813-820. Epub 2017 Jul 18.

a Department of Leukemia , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

The purine nucleoside analogues clofarabine and fludarabine are active in acute myeloid leukemia (AML). We conducted a phase I/II randomized study of idarubicin and cytarabine with either clofarabine (CIA) or fludarabine (FIA) for relapsed or refractory AML. Clofarabine 15 mg/m was identified as the recommended phase II dose. Read More

View Article
April 2018
13 Reads
2 PubMed Central Citations(source)

Association of high serum vitamin D concentrations with active pulmonary TB in an HIV co-endemic setting, Harare, Zimbabwe.

BMC Infect Dis 2017 02 13;17(1):142. Epub 2017 Feb 13.

Department of Chemical Pathology, University of Zimbabwe, College of Health Sciences, P.O. Box A178, Avondale, Harare, Zimbabwe.

Background: There is paucity data on the association of vitamin D deficiency (VDD) and active tuberculosis (TB) in southern Africa where the human immunodeficiency virus (HIV) is co-endemic. We examined the association of serum vitamin D concentrations with active pulmonary tuberculosis (PTB) in HIV-infected (n = 284) and uninfected (n = 267) Black Zimbabweans, in Harare, Zimbabwe.

Methods: We conducted a cross-sectional study of 551 participants comprising 145 HIV/PTB , 139 HIV/PTB, 134 HIV/PTB and 133 HIV/PTB. Read More

View Article
February 2017
21 Reads
2 PubMed Central Citations(source)
2.61 Impact Factor

Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment.

Mol Cancer Res 2017 03 5;15(3):281-293. Epub 2017 Jan 5.

UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.

Prostate cancer is the second most common cancer in men worldwide. Gleason grading is an important predictor of prostate cancer outcomes and is influential in determining patient treatment options. Clinical decisions based on a Gleason score of 7 are difficult as the prognosis for individuals diagnosed with Gleason 4+3 cancer is much worse than for those diagnosed with Gleason 3+4 cancer. Read More

View Article
March 2017
16 Reads
3 PubMed Central Citations(source)
4.38 Impact Factor

Influence of exogenous application of glycinebetaine on antioxidative system and growth of salt-stressed soybean seedlings (Glycine max L.).

Physiol Mol Biol Plants 2015 Apr 26;21(2):225-32. Epub 2015 Mar 26.

Department of Biology, Faculty of Sciences, University of Qom, Qom, Iran.

Glycinebetaine is one of the most competitive compounds which play an important role in salt stress in plants. In this study, the enhanced salt tolerance in soybean (Glycine max L.) by exogenous application of glycinebetaine was evaluated. Read More

View Article
April 2015
1 Read
2 PubMed Central Citations(source)